Mid-Market Update: This morning, I covered the breakout in Pfizer’s (PFE, $31.75, down $0.22) chart and what it could mean for our option trades with February and March expirations. Now that I have reviewed the chart work, let’s take a look at the fundamentals.

This content is for Momentum Options – 6 Months, Momentum Options – 1 Year and Momentum Options – 2 Years members only.
Log In Register